Heidelberg Pharma AG
XMUN:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
Heidelberger Druckmaschinen AG
F:HDDF
|
DE |
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
Teleperformance SE
F:RCF0
|
FR |
|
M
|
MKS Instruments Inc
F:MKT
|
US |
|
Ence Energia y Celulosa SA
F:ENCA
|
ES |
|
F
|
Fluor Corp
SWB:FLU
|
US |
|
Oxford Square Capital Corp
F:22T
|
US |
|
E
|
EVN AG
XMUN:EVN
|
AT |
|
I
|
International Flavors & Fragrances Inc
XMUN:IFF
|
US |
|
G
|
Genfit SA
PAR:GNFT
|
FR |
|
E
|
Esprinet SpA
F:EP4A
|
IT |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for HPHA is 5.57 EUR with a low forecast of 5.51 EUR and a high forecast of 5.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.57
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.57 EUR with a low forecast of 5.51 EUR and a high forecast of 5.73 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 26%.
